Xconomy | Kendall Square - 
					Business + Technology in the Exponential Economy

Archives

by in
Entry Blogger Date  ▴ Xconomist Location
FDA Decision a Blow For Genzyme—and Biogenerics? Rebecca Zacks 04/22/08 Boston
GTC Biotherapeutics, Racing Against Time to Prove the Worth of “Pharming” David Stipp 02/11/08 Boston
Setback for Momenta, Setback for Biogenerics? Rebecca Zacks 11/08/07 Boston
The State of Biotechnology, According to Biogen Idec CEO Jim Mullen Robert Buderi 08/16/07 Boston
Genzyme’s Myozyme Production Problems Fuel Online Biogenerics Debate Rebecca Zacks 08/10/07 Boston
Page 1 of 1
    

© 2007 Xconomy. All rights reserved. Site designed by Matthew Bouchard, produced by Andrew Koyfman, and powered by WordPress.